Navigation Links
Man-made heart tissue improves cardiac performance

Researchers have developed a method to engineer blood vessels within the tissue of previously engineered heart muscle. Trials have resulted in significant improvement in heart function. The study is published in the journal Artificial Organs.

With heart disorders affecting individuals globally and contributing to increasing mortality rates, there has been a need to develop new treatment options. One of the specific challenges in the field of tissue engineering is to produce blood vessels within heart muscle tissue. In this study, the researchers were successful in this task. Their live models showed significant improvement in heart function, particularly in the amount of vascularization throughout the implanted sections. Further, the tissue engineered construct remained viable even after the three-week implantation period, maintaining cardiac specific function.

"The long-term goal of cardiac tissue engineering is to generate functional cardiac muscle in vitro," states lead researcher, Ravi K. Birla. "Work in this area would lead to the formation of functional heart muscle that can someday help patients with acute heart failure."

Tissue-engineered heart muscle can be used to treat cases of myocardial infarction and to repair congenital heart defects, as well as in the use of drug development to provide insight into cardiac developmental biology.


'"/>

Source:Blackwell Publishing Ltd.


Page: 1

Related biology news :

1. Man-made wetlands effectiveness similar to natural marsh
2. UCSD team discovers specialized, rare heart stem cells in newborns
3. Single stem cells from bone heal a broken heart
4. Python a hearty eater
5. Columbia study shows widely used artery clearing device does not help patients during heart attack
6. Researchers reveal secret of key protein in brain and heart function
7. Stem cell therapy successfully treats heart attack in animals
8. New defibrillator signals doctor of patients irregular heartbeat or device malfunction
9. Survival of heart patients on beta-blockers varies greatly with genetic variation
10. Chemical band-aid prevents heart failure in mice with muscular dystrophy
11. MicroRNA tweaks protein that controls early heart development
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/4/2017)... Oct. 4, 2017  GCE Solutions, a global clinical research organization ... document anonymization solution on October 4, 2017. Shadow is designed to ... comply with policy 0070 of the European Medicines Agency (EMA) in ... ... ...
(Date:6/30/2017)... , June 30, 2017 Today, American ... and supplier of face and eye tracking software, ... Product provider program. "Artificial intelligence ... way to monitor a driver,s attentiveness levels while ... being able to detect fatigue and prevent potential ...
(Date:5/16/2017)... N.J. , May 16, 2017  Veratad Technologies, ... provider of online age and identity verification solutions, announced ... K(NO)W Identity Conference 2017, May 15 thru May 17, ... Regan Building and International Trade Center. ... the globe and in today,s quickly evolving digital world, ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... ... October 12, 2017 , ... BioMedGPS announces ... addition of its newest module, US Hemostats & Sealants. , SmartTRAK’s US Market ... hemostats, fibrin sealants, synthetic sealants and biologic sealants used in surgical applications. BioMedGPS ...
(Date:10/11/2017)... ... October 11, 2017 , ... At its national board meeting ... I. Sheikh, the co-founder, CEO and chief research scientist of Minnesota-based Advanced Space ... membership in ARCS Alumni Hall of Fame . ASTER Labs is a ...
(Date:10/11/2017)... ... , ... ComplianceOnline’s Medical Device Summit is back for its 4th year. The ... Francisco, CA. The Summit brings together current and former FDA office bearers, regulators, industry ... officials from around the world to address key issues in device compliance, quality and ...
(Date:10/11/2017)... LAGUNA HILLS, Calif. , Oct. 11, 2017  SkylineDx ... London (ICR) and University of Leeds ... to risk-stratify patients with multiple myeloma (MM), in a multi-centric ... The University of Leeds is the ... UK, and ICR will perform the testing services to include ...
Breaking Biology Technology: